Cutaneous reactions to COVID-19 vaccine at the dermatology primary care


Martina Burlando, Astrid Herzum, Claudia Micalizzi, Emanuele Cozzani, Aurora Parodi, Immunity, Inflammation and Disease Volume 10, Issue 2 p. 265-271 Abstract Introduction Coronavirus disease 2019 (COVID-19) vaccines can cause adverse reactions, mainly from vaccine-induced immune responses. Some of these may also involve the skin and worry unaware patients. A better understanding of such adverse reactions may reduce concerns and help […]

COVID-19 Vaccination May Be Associated With Psoriasis


Colby Stong, September 19, 2022 Dermatology Advisor New-onset psoriasis and psoriasis flares are potential cutaneous adverse events after COVID-19 vaccination, according to study findings published in the American Journal of Clinical Dermatology. Researchers conducted a systematic review to evaluate the demographic and clinical factors and outcomes associated with psoriasis after COVID-19 vaccination. They searched the PubMed, Embase, […]

Serum vitamin D levels can be predictive of psoriasis flares up after COVID-19 vaccination: a retrospective case control study


Emmanouil Karampinis1 George Goudouras1 Niki Ntavari1 Dimitrios Petrou Bogdanos2† Angeliki-Victoria Roussaki-Schulze1† Efterpi Zafiriou1*† Front. Med., 25 May 2023 Sec. Dermatology Volume 10 – 2023 | https://doi.org/10.3389/fmed.2023.1203426 Introduction: Many patients with chronic inflammatory dermatosis such as psoriasis usually ask about the safety of COVID-19 vaccination and if it would affect the course of their disease. Indeed, many case reports, case series and clinical […]

New onset and exacerbation of psoriasis after COVID-19 vaccination


Nancy Wei, BA,a,∗ Mindy Kresch, BS,b Emily Elbogen, PA-C,c and Mark Lebwohl, MDc JAAD Case Rep. 2022 Jan; 19: 74–77. Published online 2021 Nov 29. doi: 10.1016/j.jdcr.2021.11.016 PMCID: PMC8628636 PMID: 34869811 Introduction The messenger RNA (mRNA)-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) vaccines were granted emergency use authorization during the ongoing COVID-19 pandemic by the United States Food and Drug Administration in December 2020.1 An adenoviral vector […]

Skin reactions to COVID-19 vaccines?  


2020-January 18 The coronavirus disease 2019 (COVID-19) pandemic has led to the development and approval of vaccines against the responsible virus — severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). More than 100 companies and institutions worldwide have developed vaccine candidates.  How do the COVID-19 vaccines differ? Current approved vaccines rely on a nucleic-acid-based vaccine platform Messenger ribonucleic acid (mRNA) eg, Pfizer/BioNTech + Fosun Pharma, Moderna + National Institute […]

Psoriasis and COVID-19 Vaccine: What to Know


Authors: Christine Zink, MD  Updated on October 19, 2022 Medically reviewed by Casey Gallagher, MD Very Well Health Oct 19, 2022 Psoriasis is a skin disorder characterized by thick, inflamed patches with silvery scales. It is a complex autoimmune and inflammatory disorder in which immune cells inappropriately attack the skin cells, leading to rapid replacement and buildup.1 Psoriasis […]

New onset and exacerbation of psoriasis after COVID-19 vaccination


Authors: Nancy Wei, BA,a,∗ Mindy Kresch, BS,b Emily Elbogen, PA-C,c and Mark Lebwohl, MDc JAAD Case Rep. 2022 Jan; 19: 74–77. Published online 2021 Nov 29. doi: 10.1016/j.jdcr.2021.11.016 PMCID: PMC8628636PMID: 34869811 Introduction The messenger RNA (mRNA)-1273 (Moderna) and BNT162b2 (Pfizer-BioNTech) vaccines were granted emergency use authorization during the ongoing COVID-19 pandemic by the United States Food and Drug Administration […]

Psoriasis Flares in Patients With COVID-19 Infection or Vaccination: A Case Series


Authors: Hemali Shah, Ana C. Busquets Published: June 16, 2022 (see history) DOI: 10.7759/cureus.25987 Cite this article as: Shah H, Busquets A C (June 16, 2022) Psoriasis Flares in Patients With COVID-19 Infection or Vaccination: A Case Series. Cureus 14(6): e25987. doi:10.7759/cureus.25987 Abstract Much of the literature involving COVID-19 and chronic inflammatory dermatological conditions have focused on the safety of […]